Cochrane Hypertension

Cochrane Hypertension The Cochrane Hypertension Group is committed to helping people make well-informed decisions about prevention and treatment of hypertension.

🆕 We've published a new Cochrane   protocol:Blood pressure lowering efficacy of dual glucose-dependent insulinotropic po...
04/21/2025

🆕 We've published a new Cochrane protocol:

Blood pressure lowering efficacy of dual glucose-dependent insulinotropic polypeptide/glucagon-like peptide-1 (GIP/GLP-1) receptor agonists compared to glucagon-like peptide-1 (GLP-1) receptor agonists
https://doi.org/10.1002/14651858.CD016144

🚨Updated Cochrane  :Withdrawal of antihypertensive drugs in older people 💊https://doi.org/10.1002/14651858.CD012572.pub3...
04/11/2025

🚨Updated Cochrane :

Withdrawal of antihypertensive drugs in older people 💊
https://doi.org/10.1002/14651858.CD012572.pub3

"Future research should focus on populations with the greatest uncertainty of the benefit:risk ratio"



The Cochrane Library Cochrane Canada Cochrane New Zealand

  webinar recordingDebunking some of the hype in  ti.ubc.ca/drugevidence24Dr. James Wright summarizes latest evidence on...
03/04/2025

webinar recording

Debunking some of the hype in
ti.ubc.ca/drugevidence24

Dr. James Wright summarizes latest evidence on :

⏰ chronotherapy
💊 first line tx
🎯 blood pressure targets
⚠️ treatment efficacy + safety

🆕Cochrane  🎺  Renin inhibitors versus angiotensin receptor blockers for primary   https://www.cochranelibrary.com/cdsr/d...
02/27/2025

🆕Cochrane 🎺

Renin inhibitors versus angiotensin receptor blockers for primary
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012570.pub2

Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in About Cookies.

🆕   webinar recordingDebunking some of the hype in  ti.ubc.ca/drugevidence24Dr. James Wright summarizes latest evidence ...
02/24/2025

🆕 webinar recording

Debunking some of the hype in
ti.ubc.ca/drugevidence24

Dr. James Wright summarizes latest evidence on : https://www.youtube.com/watch?v=ZS8Y7OfNxPI

⏰ chronotherapy
💊 first line tx
🎯 blood pressure targets
⚠️ treatment efficacy + safety

TI 2024 Annual Conference: Debunking some of the hype in hypertension. Presented by Dr. James (Jim) Wright on 19 October 2024.

🆕For people with high   (BP) & chronic renal disease, evidence does NOT support lower than standard BP targets🚨Our The C...
10/15/2024

🆕For people with high (BP) & chronic renal disease, evidence does NOT support lower than standard BP targets🚨

Our The Cochrane Library systematic review looks at evidence from 6 trials involving 7,348 participants: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD008564.pub3/full



Nurses and Nurse Practitioners of BC Cochrane New Zealand Cochrane Brazil Family Doctors Resident Doctors of BC Cochrane Canada Family Medicine Cochrane Colombia

🆕 in Cochrane Clinical Answers🎺How do first‐line diuretics compare with other classes of antihypertensive drugs for adul...
07/08/2024

🆕 in Cochrane Clinical Answers🎺

How do first‐line diuretics compare with other classes of antihypertensive drugs for adults with hypertension?
https://rb.gy/d9j7y2

Address

2176 Health Sciences Mall
Vancouver, BC
V6T1Z3

Alerts

Be the first to know and let us send you an email when Cochrane Hypertension posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Cochrane Hypertension:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram